Microbiol S.r.l.

Microbiol S.r.l. specializes in microbiological culture media and selective agars designed for identifying and isolating specific bacteria. Their products include media like Weil Felix, Burkholderia cepacia selective agar, and Gardnerella vaginalis agar, as well as specialized formulations such as thioglycollate broth with added vitamins and antibiotics, chocolate agar with bacitracin, and agars for detecting antibiotic-resistant strains like MRSA and VRE. These devices are primarily used in clinical microbiology labs for diagnostic purposes.

Microbiol S.r.l. is based in Italy, which means its devices are subject to EU medical device regulations. Since all its microbiological media and diagnostic products fall under EU Class A medical devices, they must comply with EU regulatory requirements for in vitro diagnostics (IVDs) and microbiological culture media. This includes registration in the EUDAMED database, ensuring traceability and adherence to EU standards for safety and performance.

Microbiol S.r.l.’s devices are listed in the EUDAMED database, which is the European Union’s central registry for medical devices. This registry ensures transparency and traceability of devices placed on the EU market, allowing healthcare professionals, regulators, and authorities to verify the legitimacy and compliance status of the listed products. Being listed here confirms that the devices meet EU regulatory requirements, though individual device authorization is determined separately.

All of Microbiol S.r.l.’s microbiological culture media and diagnostic products are classified as EU Class A medical devices. This classification applies to low-risk devices, such as microbiological media used for identifying bacteria in controlled laboratory settings. Class A devices typically undergo less stringent regulatory scrutiny compared to higher-risk classes, but they still must comply with essential safety and performance requirements to ensure their intended use is met without posing undue risks to patients or users.